Sandbox Reserved 1713
From Proteopedia
(Difference between revisions)
												
			
			| Line 18: | Line 18: | ||
| == Disease == | == Disease == | ||
| <scene name='90/904318/Premutationresidues/2'>mutated residues</scene> | <scene name='90/904318/Premutationresidues/2'>mutated residues</scene> | ||
| - | <scene name='90/904318/His694/ | + | <scene name='90/904318/His694/2'>His694</scene> | 
| <scene name='90/904318/Phe856/1'>Phe856</scene> | <scene name='90/904318/Phe856/1'>Phe856</scene> | ||
| <scene name='90/904318/Arg753/2'>Arg753</scene> | <scene name='90/904318/Arg753/2'>Arg753</scene> | ||
Revision as of 00:58, 28 March 2022
| This Sandbox is Reserved from February 28 through September 1, 2022 for use in the course CH462 Biochemistry II taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1700 through Sandbox Reserved 1729. | 
| To get started: 
 More help: Help:Editing | 
Anaplastic Lymphoma Kinase
| 
 | |||||||||||
References
- ↑ Reshetnyak AV, Rossi P, Myasnikov AG, Sowaileh M, Mohanty J, Nourse A, Miller DJ, Lax I, Schlessinger J, Kalodimos CG. Mechanism for the activation of the anaplastic lymphoma kinase receptor. Nature. 2021 Dec;600(7887):153-157. doi: 10.1038/s41586-021-04140-8. Epub 2021, Nov 24. PMID:34819673 doi:http://dx.doi.org/10.1038/s41586-021-04140-8



